Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > It works 1.2 million runrate from B to B licensing agreement

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon May 31, 2021 6:13pm

79 Views

Post# 33298756

RE:It works 1.2 million runrate from B to B licensing agreement

stop stop STOP

posting PAID FOR " interviews"

my gawd do you work for them?

you are as bad as Shawn scott, who posted all day every day for crop (suspended at a roll back .02)

STOP POSTING UTTER NONSENSE!!!!!!

<< Previous

Bullboard Posts

Next >>

SSR Mining reviews deadly landslide, faces class-action lawsuits